All In Biotech

Drug Trial Radar · NCT01546142

Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of ATX-101 (Sodium Deoxycholate Injection) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

Last checked: Nov 19, 2026Latest source record: Jun 15, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 516 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

516

Actual

Start

Mar 2012

Primary completion

May 2013

Study completion Aug 2013

Sponsor

Lead sponsor
Kythera BiopharmaceuticalsIndustry
Sponsor type
Industry
First posted
Mar 7, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

To evaluate the safety and efficacy of deoxycholic acid injection in the reduction of submental fat (fat below the chin).

Conditions

  • Moderate or Severe Submental Fullness

Interventions

  • Deoxycholic acid injectionDrug

    Formulated as an injectable solution containing deoxycholic acid at a concentration of 10 mg/mL.

  • PlaceboDrug

    Phosphate buffered saline placebo for injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Who Achieved a Composite 1-grade ResponseTime frame: Baseline and 12 weeks after last treatment (up to 32 weeks after first treatment)
  2. Percentage of Participants Who Achieved a Composite 2-grade ResponseTime frame: Baseline and 12 weeks after last treatment (up to 32 weeks after first treatment)

Locations

35 sites in 2 countries. Site status is shown where the registry gives one.

  • Investigational Site

    Little Rock, Arkansas

  • Investigational Site

    Beverly Hills, California

  • Investigational Site

    Los Angeles, California

  • Investigational Site

    Sacramento, California

  • Investigational Site

    San Francisco, California

  • Investigational Site

    Santa Monica, California

  • Investigational Site

    Englewood, Colorado

  • Investigational Site

    Coral Gables, Florida

  • Investigational Site

    Jacksonville, Florida

  • Investigational Site

    Chicago, Illinois

  • Investigational Site

    Naperville, Illinois

  • Investigational Site

    Carmel, Indiana

  • Investigational Site

    South Bend, Indiana

  • Investigational Site

    Lutherville, Maryland

  • Investigational Site

    Clinton Township, Michigan

  • Investigational Site

    Edina, Minnesota

  • Investigational Site

    St Louis, Missouri

  • Investigational Site

    Montclair, New Jersey

  • Investigational Site

    New York, New York

  • Investigational Site

    New York, New York

  • Investigational Site

    White Plains, New York

  • Investigational Site

    Charlotte, North Carolina

  • Investigational Site

    High Point, North Carolina

  • Investigational Site

    Cincinnatti, Ohio

  • Investigational Site

    Portland, Oregon

  • Investigational Site

    Austin, Texas

  • Investigational Site

    Plano, Texas

  • Investigational Site

    San Antonio, Texas

  • Investigational Site

    Salt Lake City, Utah

  • Investigational Site

    Charlottesville, Virginia

  • Investigational Site

    Calgary, Alberta, Canada

  • Investigational Site

    Surrey, British Columbia, Canada

  • Investigational Site

    Vancouver, British Columbia, Canada

  • Investigational Site

    Oakville, Ontario, Canada

  • Investigational Site

    Woodbridge, Ontario, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.